CWM LLC decreased its position in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 15.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 159,085 shares of the company's stock after selling 28,492 shares during the period. CWM LLC's holdings in UiPath were worth $1,639,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently modified their holdings of the company. Proficio Capital Partners LLC bought a new stake in shares of UiPath during the fourth quarter valued at approximately $307,000. Raymond James Financial Inc. bought a new stake in shares of UiPath during the fourth quarter valued at approximately $5,506,000. Corient Private Wealth LLC grew its stake in shares of UiPath by 24.5% during the fourth quarter. Corient Private Wealth LLC now owns 17,133 shares of the company's stock valued at $218,000 after purchasing an additional 3,374 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in shares of UiPath by 72.3% during the fourth quarter. Thrivent Financial for Lutherans now owns 35,970 shares of the company's stock valued at $457,000 after purchasing an additional 15,089 shares during the last quarter. Finally, Xponance Inc. grew its stake in shares of UiPath by 5.2% during the fourth quarter. Xponance Inc. now owns 53,192 shares of the company's stock valued at $676,000 after purchasing an additional 2,630 shares during the last quarter. Institutional investors and hedge funds own 62.50% of the company's stock.
UiPath Price Performance
NYSE:PATH traded up $0.01 on Wednesday, hitting $12.60. 14,481,181 shares of the company's stock were exchanged, compared to its average volume of 10,523,385. The firm has a 50-day moving average price of $12.71 and a 200-day moving average price of $12.44. UiPath, Inc. has a 52 week low of $9.38 and a 52 week high of $15.93. The company has a market cap of $6.74 billion, a P/E ratio of -104.95, a price-to-earnings-growth ratio of 13.23 and a beta of 1.04.
UiPath (NYSE:PATH - Get Free Report) last released its quarterly earnings data on Thursday, May 29th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.01. The company had revenue of $356.62 million for the quarter, compared to analyst estimates of $332.17 million. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. UiPath's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.13 EPS. On average, research analysts expect that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several analysts have recently commented on PATH shares. Barclays reissued an "equal weight" rating on shares of UiPath in a research note on Friday, May 30th. Mizuho lowered their target price on shares of UiPath from $12.00 to $11.00 and set a "neutral" rating for the company in a report on Tuesday, April 15th. Wells Fargo & Company reaffirmed an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Needham & Company LLC reaffirmed a "hold" rating on shares of UiPath in a report on Friday, May 30th. Finally, Evercore ISI lifted their target price on shares of UiPath from $11.00 to $15.00 and gave the stock an "in-line" rating in a report on Friday, May 30th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, UiPath currently has a consensus rating of "Hold" and an average target price of $13.83.
View Our Latest Report on UiPath
Insider Activity
In related news, CEO Daniel Dines sold 45,000 shares of the company's stock in a transaction dated Monday, July 14th. The shares were sold at an average price of $12.44, for a total value of $559,800.00. Following the transaction, the chief executive officer owned 5,148,376 shares in the company, valued at approximately $64,045,797.44. This represents a 0.87% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Ashim Gupta sold 98,795 shares of the company's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $12.01, for a total transaction of $1,186,527.95. Following the completion of the transaction, the chief financial officer owned 987,322 shares in the company, valued at approximately $11,857,737.22. This trade represents a 9.10% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 785,117 shares of company stock worth $9,854,444 over the last 90 days. 23.19% of the stock is owned by company insiders.
About UiPath
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Recommended Stories

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.